Concepedia
Statistics
Publications
12
Citations
729
H-Index
11
Active since
1987
Affiliations
Eli Lilly (United States)(Current)
Research Triangle Park Foundation
Indiana University – Purdue University Indianapolis
Indiana University School of Medicine
Purdue University West Lafayette
Mark A. Carfagna is an author at Eli Lilly (United States) specializing in medicine, physiology, and pharmacology.
Top concepts
MedicinePhysiologyPharmacologyToxicologyBiochemistryLiver PhysiologyHepatologyMetabolismNatural SciencesOxidative Stress
Publications per year
1987–2019
Temporal Gene Expression Analysis of Monolayer Cultured Rat Hepatocytes
Thomas K. Baker, Mark A. Carfagna, Hong Gao et al. · Chemical Research in Toxicology · 2001 · 146 citations
Gene Expression Changes, Cell Culture, Gene Expression Profiling +18
Kinetic Analysis of Furan Biotransformation by F-344 Rats in Vivo and in Vitro
G.L. Kedderis, Mark A. Carfagna, S.D. Held et al. · Toxicology and Applied Pharmacology · 1993 · 128 citations
F-344 Rats, Biotransformation, Biochemistry +7
Inhibition of ATPase activity in rat synaptic plasma membranes by simultaneous exposure to metals
Mark A. Carfagna, G. Douglas Ponsler, Barry B. Muhoberac · Chemico-Biological Interactions · 1996 · 75 citations
Atpase Activity, Simultaneous Exposure, Biochemistry +9
Comparison of Plasma, Serum, and Whole Blood Ethanol Concentrations
Charles L. Winek, Mark A. Carfagna · Journal of Analytical Toxicology · 1987 · 69 citations
Biological Characterization of a Heterodimer-Selective Retinoid X Receptor Modulator: Potential Benefits for the Treatment of Type 2 Diabetes
Mark D. Leibowitz, Robert Ardecky, Marcus F. Boehm et al. · Endocrinology · 2005 · 69 citations · Full text
1–5 of 12